Safety of Phosphodiesterase-5 Inhibitors in Valvular Heart Disease.
J Cardiovasc Pharmacol. 2021 Sep 1;78(3):372-376. doi: 10.1097/FJC.0000000000001071.
J Cardiovasc Pharmacol. 2021.
PMID: 34074904
Review.